From July 1 to July 4, 2018, Barcelona hosted the ESHRE 34th Annual Meeting, bringing together over 12,000 global experts, clinical embryologists, reproductive endocrinologists, and medical device manufacturers.
The scientific program highlighted emerging trends in non-invasive preimplantation genetic testing (niPGT-A), continuous culture media optimization, and heightened safety protocols for oocyte and embryo vitrification.
Delegates from LLC ART MEDICAL LTD actively worked at the congress to strengthen supply channels and explore advanced technological solutions for Ukrainian fertility clinics.
Key Working Priorities:
-
Technical Portfolio Review: Conducted in-depth B2B sessions with executives of our principal manufacturing partners to evaluate the specifications of newly developed microinstruments and media formulations prior to their global rollout;
-
Transfer of Clinical Insights: Presented foreign engineering teams with a consolidated analysis of product application across Ukrainian IVF units, highlighting specific handling preferences and observations from local embryologists;
-
Supply Chain Optimization & Forecasting: Assessed product consumption trends within domestic medical centers, adjusted import volume targets, and structured delivery schedules to maintain continuous warehouse reserves in Ukraine.
Participating in the 34th ESHRE Annual Meeting 2018 in Barcelona enabled ART MEDICAL to reinforce its international distribution partnerships, ensuring that Ukrainian clinics receive continuous access to premium-quality medical supplies.
We express our gratitude to our global partners for their trust, constructive dialogue, and long-standing collaboration!